| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 19.516 | 52.582 | 72.092 | 87.651 | 73.702 | 79.244 |
| Total Income - EUR | - | - | - | - | 23.754 | 60.467 | 76.125 | 91.696 | 82.157 | 79.688 |
| Total Expenses - EUR | - | - | - | - | 6.962 | 19.680 | 22.822 | 24.907 | 30.938 | 38.872 |
| Gross Profit/Loss - EUR | - | - | - | - | 16.792 | 40.787 | 53.303 | 66.789 | 51.219 | 40.816 |
| Net Profit/Loss - EUR | - | - | - | - | 16.436 | 40.464 | 52.598 | 65.930 | 50.556 | 38.486 |
| Employees | - | - | - | - | 1 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Pro Neuromed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 23.742 | 25.233 | 20.596 | 16.570 | 36.951 | 26.996 |
| Current Assets | - | - | - | - | 26.020 | 45.520 | 5.439 | 72.958 | 32.621 | 32.620 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 4.246 | 0 |
| Receivables | - | - | - | - | 25.370 | 37.875 | 0 | 65.628 | 3.462 | 24.616 |
| Cash | - | - | - | - | 651 | 7.645 | 5.439 | 7.329 | 24.914 | 8.004 |
| Shareholders Funds | - | - | - | - | 16.478 | 45.569 | 2.710 | 68.649 | 53.961 | 41.189 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 0 | 410 | 3.126 | 4.657 | 1.002 | 8.557 |
| Income in Advance | - | - | - | - | 33.284 | 24.775 | 20.199 | 16.222 | 14.609 | 9.869 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Pro Neuromed S.r.l.